A detailed history of Voya Investment Management LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 1,032,716 shares of FOLD stock, worth $10.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,032,716
Previous 970,313 6.43%
Holding current value
$10.2 Million
Previous $13.8 Million 11.64%
% of portfolio
0.01%
Previous 0.02%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$11.43 - $14.24 $713,266 - $888,618
62,403 Added 6.43%
1,032,716 $12.2 Million
Q4 2023

Feb 14, 2024

BUY
$9.97 - $14.52 $2.39 Million - $3.48 Million
239,792 Added 32.82%
970,313 $13.8 Million
Q3 2023

Nov 14, 2023

SELL
$11.78 - $13.86 $1.64 Million - $1.93 Million
-139,308 Reduced 16.02%
730,521 $8.88 Million
Q2 2023

Aug 14, 2023

BUY
$10.72 - $13.3 $1.68 Million - $2.08 Million
156,434 Added 21.93%
869,829 $10.9 Million
Q1 2023

May 15, 2023

SELL
$10.91 - $13.54 $97,306 - $120,763
-8,919 Reduced 1.23%
713,395 $7.91 Million
Q4 2022

Feb 14, 2023

BUY
$9.89 - $12.7 $1.69 Million - $2.17 Million
170,677 Added 30.94%
722,314 $8.82 Million
Q3 2022

Mar 03, 2023

SELL
$9.82 - $12.75 $1.68 Million - $2.18 Million
-170,677 Reduced 23.63%
551,637 $5.76 Million
Q3 2022

Nov 14, 2022

BUY
$9.82 - $12.75 $113,224 - $147,007
11,530 Added 2.13%
551,637 $5.76 Million
Q2 2022

Aug 15, 2022

BUY
$6.23 - $11.12 $2.71 Million - $4.84 Million
434,825 Added 413.01%
540,107 $5.8 Million
Q1 2022

May 16, 2022

SELL
$7.89 - $12.48 $2.36 Million - $3.74 Million
-299,608 Reduced 74.0%
105,282 $997,000
Q4 2021

Feb 14, 2022

SELL
$9.82 - $12.44 $3.7 Million - $4.69 Million
-377,125 Reduced 48.22%
404,890 $4.68 Million
Q3 2021

Nov 15, 2021

SELL
$8.74 - $11.84 $382,278 - $517,869
-43,739 Reduced 5.3%
782,015 $7.47 Million
Q2 2021

Aug 16, 2021

BUY
$8.71 - $10.72 $849,338 - $1.05 Million
97,513 Added 13.39%
825,754 $7.96 Million
Q1 2021

May 17, 2021

BUY
$9.2 - $23.86 $407,136 - $1.06 Million
44,254 Added 6.47%
728,241 $7.2 Million
Q4 2020

Feb 16, 2021

SELL
$13.47 - $24.89 $4.37 Million - $8.08 Million
-324,557 Reduced 32.18%
683,987 $15.8 Million
Q3 2020

Nov 16, 2020

SELL
$12.89 - $15.89 $1.41 Million - $1.74 Million
-109,562 Reduced 9.8%
1,008,544 $14.2 Million
Q2 2020

Aug 14, 2020

SELL
$8.86 - $15.69 $2.49 Million - $4.41 Million
-281,357 Reduced 20.1%
1,118,106 $16.9 Million
Q1 2020

May 15, 2020

SELL
$6.63 - $11.16 $662,794 - $1.12 Million
-99,969 Reduced 6.67%
1,399,463 $12.9 Million
Q4 2019

Feb 14, 2020

SELL
$7.48 - $10.75 $5.85 Million - $8.41 Million
-782,365 Reduced 34.29%
1,499,432 $14.6 Million
Q3 2019

Nov 14, 2019

BUY
$8.02 - $13.25 $3.87 Million - $6.39 Million
481,964 Added 26.78%
2,281,797 $18.3 Million
Q2 2019

Aug 14, 2019

SELL
$10.96 - $14.4 $1.06 Million - $1.39 Million
-96,261 Reduced 5.08%
1,799,833 $22.5 Million
Q1 2019

May 15, 2019

BUY
$10.04 - $13.92 $2.88 Million - $3.99 Million
286,786 Added 17.82%
1,896,094 $25.8 Million
Q4 2018

Feb 14, 2019

SELL
$8.38 - $13.44 $729,160 - $1.17 Million
-87,012 Reduced 5.13%
1,609,308 $15.4 Million
Q3 2018

Nov 14, 2018

BUY
$11.6 - $16.54 $4.21 Million - $6 Million
362,824 Added 27.21%
1,696,320 $20.5 Million
Q2 2018

Aug 14, 2018

SELL
$13.13 - $17.09 $599,778 - $780,671
-45,680 Reduced 3.31%
1,333,496 $20.8 Million
Q1 2018

May 15, 2018

BUY
$13.76 - $17.12 $2.26 Million - $2.81 Million
163,937 Added 13.49%
1,379,176 $20.7 Million
Q4 2017

Feb 14, 2018

BUY
$12.51 - $16.24 $14.3 Million - $18.5 Million
1,139,120 Added 1496.5%
1,215,239 $17.5 Million
Q3 2017

Nov 14, 2017

BUY
$11.74 - $15.78 $893,637 - $1.2 Million
76,119
76,119 $1.15 Million

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.78B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.